- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Bright Health is hemorrhaging money, raising questions not only about its future but also about its increasingly close relationship with Cigna, which has become a major investor. Bright, one
of the largest startups combining health insurance and doctor clinics, disclosed this week that it lost almost $1.2 billion in 2021 and will lose upward of $800 million this year,
suggesting it will quickly burn through the $550 million cash injection Cigna extended in January. Some of those losses were expected, but some — such as Bright struggling with basic medical
claims technology — were surprising. Even as Bright struggles, however, it’s growing closer to Cigna. This week Bright added Matt Manders, a 30-year veteran executive of Cigna, to its
board. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE — PLUS DAILY MARKET-MOVING BIOPHARMA ANALYSIS — BY SUBSCRIBING
TO STAT+. Already have an account? Log in Individual plans Group plans View All Plans To read the rest of this story subscribe to STAT+. Subscribe
